Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes

•LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity. Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience 2016-06, Vol.324, p.485-495
Hauptverfasser: Martins, D.F, Turnes, B.L, Cidral-Filho, F.J, Bobinski, F, Rosas, R.F, Danielski, L.G, Petronilho, F, Santos, A.R.S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 495
container_issue
container_start_page 485
container_title Neuroscience
container_volume 324
creator Martins, D.F
Turnes, B.L
Cidral-Filho, F.J
Bobinski, F
Rosas, R.F
Danielski, L.G
Petronilho, F
Santos, A.R.S
description •LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity. Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesia and inflammatory processes. Nevertheless, scientific data on the mechanisms responsible for the therapeutic effect of LEDT are still insufficient. Thus, this study investigated the analgesic, anti-inflammatory and anti-oxidative effect of LEDT in the model of chronic inflammatory hyperalgesia. Experimental procedures: Mice injected with Complete Freund’s Adjuvant (CFA) underwent behavioral, i.e. mechanical and hot hyperalgesia; determination of cytokine levels (tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-10), oxidative stress markers (protein carbonyls and thiobarbituric acid reactive species (TBARS)) and antioxidant enzymes (catalase (CAT) and superoxide dismutase (SOD)). Additionally, mice were pretreated with either naloxone or fucoidin and mechanical hyperalgesia was assessed. Results: LEDT inhibited mechanical and thermal hyperalgesia induced by CFA injection. LEDT did not reduce paw edema, neither influenced the levels of TNF-α and IL1-β; although it increased the levels of IL-10. LEDT significantly prevented TBARS increase in both acute and chronic phases post-CFA injection; whereas protein carbonyl levels were reduced only in the acute phase. LEDT induced an increase in both SOD and CAT activity, with effects observable in the acute but not in the chronic. And finally, pre-administration of naloxone or fucoidin prevented LEDT analgesic effect. Conclusions: These data contribute to the understanding of the neurobiological mechanisms involved in the therapeutic effect of LEDT as well as provides additional support for its use in the treatment of painful conditions of inflammatory etiology.
doi_str_mv 10.1016/j.neuroscience.2016.03.035
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1787976498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306452216300057</els_id><sourcerecordid>1783339787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-bf14ad34effa862af50a9c811c7ba9df1f77ab3a57c8ca8f9d03112669fd7ee53</originalsourceid><addsrcrecordid>eNqNUsFq3DAQFaUl2Sb5hSJ66sVbybItO4dCSZO2sFBok7PQSqNEG1tyJLnE_frI7KaUniJGDEhv3gzzHkLvKVlTQpuPu7WDKfioLDgF6zK_rQnLUb9CK9pyVvC6ql6jFWGkKaq6LI_R2xh3JJ-6YkfouOSEUMq7FXrY2Nu7VMBgU7LuFmvrNeB0B0GOMw6gJwURjxCijQlcwtaZXg6DTD7MeJTWneOfvgfsTf5KEHqY7q3DlGDpdL7J-kerc8bg_swDxFP0xsg-wtkhn6Cbq8vri2_F5sfX7xefN4WqmjYVW0MrqVkFxsi2KaWpiexUS6niW9lpQw3ncstkzVWrZGs6TRilZdN0RnOAmp2gD3veMfiHCWISg40K-l468FMUlLe8403VtS-BMsa6XJCh53uoygLEAEaMwQ4yzIISsagjduJfdcSijiAsxzLSu0OfaTuA_lv6LEcGfNkDIC_mt4UgDjTaBlBJaG9f1ufTfzSqt84q2d_DDHHnp-Dy6gUVsRRE_Fp8stiENmyxCGdPTYO_PQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1783339787</pqid></control><display><type>article</type><title>Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Martins, D.F ; Turnes, B.L ; Cidral-Filho, F.J ; Bobinski, F ; Rosas, R.F ; Danielski, L.G ; Petronilho, F ; Santos, A.R.S</creator><creatorcontrib>Martins, D.F ; Turnes, B.L ; Cidral-Filho, F.J ; Bobinski, F ; Rosas, R.F ; Danielski, L.G ; Petronilho, F ; Santos, A.R.S</creatorcontrib><description>•LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity. Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesia and inflammatory processes. Nevertheless, scientific data on the mechanisms responsible for the therapeutic effect of LEDT are still insufficient. Thus, this study investigated the analgesic, anti-inflammatory and anti-oxidative effect of LEDT in the model of chronic inflammatory hyperalgesia. Experimental procedures: Mice injected with Complete Freund’s Adjuvant (CFA) underwent behavioral, i.e. mechanical and hot hyperalgesia; determination of cytokine levels (tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-10), oxidative stress markers (protein carbonyls and thiobarbituric acid reactive species (TBARS)) and antioxidant enzymes (catalase (CAT) and superoxide dismutase (SOD)). Additionally, mice were pretreated with either naloxone or fucoidin and mechanical hyperalgesia was assessed. Results: LEDT inhibited mechanical and thermal hyperalgesia induced by CFA injection. LEDT did not reduce paw edema, neither influenced the levels of TNF-α and IL1-β; although it increased the levels of IL-10. LEDT significantly prevented TBARS increase in both acute and chronic phases post-CFA injection; whereas protein carbonyl levels were reduced only in the acute phase. LEDT induced an increase in both SOD and CAT activity, with effects observable in the acute but not in the chronic. And finally, pre-administration of naloxone or fucoidin prevented LEDT analgesic effect. Conclusions: These data contribute to the understanding of the neurobiological mechanisms involved in the therapeutic effect of LEDT as well as provides additional support for its use in the treatment of painful conditions of inflammatory etiology.</description><identifier>ISSN: 0306-4522</identifier><identifier>EISSN: 1873-7544</identifier><identifier>DOI: 10.1016/j.neuroscience.2016.03.035</identifier><identifier>PMID: 27001179</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Animals ; Antioxidants - metabolism ; Catalase - metabolism ; Disease Models, Animal ; Freund's Adjuvant ; Hot Temperature ; Hyperalgesia - metabolism ; Hyperalgesia - therapy ; inflammation ; Inflammation - metabolism ; Inflammation - therapy ; Interleukin-10 - metabolism ; Interleukin-1beta - metabolism ; low-level light therapy ; Male ; Mice ; Neurology ; Oxidative Stress - physiology ; Pain - metabolism ; Pain Management - instrumentation ; Pain Management - methods ; persistent pain ; Phototherapy - instrumentation ; Phototherapy - methods ; Superoxide Dismutase - metabolism ; Thiobarbituric Acid Reactive Substances - metabolism ; Touch ; Treatment Outcome ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Neuroscience, 2016-06, Vol.324, p.485-495</ispartof><rights>2016 IBRO</rights><rights>Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-bf14ad34effa862af50a9c811c7ba9df1f77ab3a57c8ca8f9d03112669fd7ee53</citedby><cites>FETCH-LOGICAL-c468t-bf14ad34effa862af50a9c811c7ba9df1f77ab3a57c8ca8f9d03112669fd7ee53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0306452216300057$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27001179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martins, D.F</creatorcontrib><creatorcontrib>Turnes, B.L</creatorcontrib><creatorcontrib>Cidral-Filho, F.J</creatorcontrib><creatorcontrib>Bobinski, F</creatorcontrib><creatorcontrib>Rosas, R.F</creatorcontrib><creatorcontrib>Danielski, L.G</creatorcontrib><creatorcontrib>Petronilho, F</creatorcontrib><creatorcontrib>Santos, A.R.S</creatorcontrib><title>Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>•LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity. Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesia and inflammatory processes. Nevertheless, scientific data on the mechanisms responsible for the therapeutic effect of LEDT are still insufficient. Thus, this study investigated the analgesic, anti-inflammatory and anti-oxidative effect of LEDT in the model of chronic inflammatory hyperalgesia. Experimental procedures: Mice injected with Complete Freund’s Adjuvant (CFA) underwent behavioral, i.e. mechanical and hot hyperalgesia; determination of cytokine levels (tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-10), oxidative stress markers (protein carbonyls and thiobarbituric acid reactive species (TBARS)) and antioxidant enzymes (catalase (CAT) and superoxide dismutase (SOD)). Additionally, mice were pretreated with either naloxone or fucoidin and mechanical hyperalgesia was assessed. Results: LEDT inhibited mechanical and thermal hyperalgesia induced by CFA injection. LEDT did not reduce paw edema, neither influenced the levels of TNF-α and IL1-β; although it increased the levels of IL-10. LEDT significantly prevented TBARS increase in both acute and chronic phases post-CFA injection; whereas protein carbonyl levels were reduced only in the acute phase. LEDT induced an increase in both SOD and CAT activity, with effects observable in the acute but not in the chronic. And finally, pre-administration of naloxone or fucoidin prevented LEDT analgesic effect. Conclusions: These data contribute to the understanding of the neurobiological mechanisms involved in the therapeutic effect of LEDT as well as provides additional support for its use in the treatment of painful conditions of inflammatory etiology.</description><subject>Animals</subject><subject>Antioxidants - metabolism</subject><subject>Catalase - metabolism</subject><subject>Disease Models, Animal</subject><subject>Freund's Adjuvant</subject><subject>Hot Temperature</subject><subject>Hyperalgesia - metabolism</subject><subject>Hyperalgesia - therapy</subject><subject>inflammation</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - therapy</subject><subject>Interleukin-10 - metabolism</subject><subject>Interleukin-1beta - metabolism</subject><subject>low-level light therapy</subject><subject>Male</subject><subject>Mice</subject><subject>Neurology</subject><subject>Oxidative Stress - physiology</subject><subject>Pain - metabolism</subject><subject>Pain Management - instrumentation</subject><subject>Pain Management - methods</subject><subject>persistent pain</subject><subject>Phototherapy - instrumentation</subject><subject>Phototherapy - methods</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Thiobarbituric Acid Reactive Substances - metabolism</subject><subject>Touch</subject><subject>Treatment Outcome</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0306-4522</issn><issn>1873-7544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUsFq3DAQFaUl2Sb5hSJ66sVbybItO4dCSZO2sFBok7PQSqNEG1tyJLnE_frI7KaUniJGDEhv3gzzHkLvKVlTQpuPu7WDKfioLDgF6zK_rQnLUb9CK9pyVvC6ql6jFWGkKaq6LI_R2xh3JJ-6YkfouOSEUMq7FXrY2Nu7VMBgU7LuFmvrNeB0B0GOMw6gJwURjxCijQlcwtaZXg6DTD7MeJTWneOfvgfsTf5KEHqY7q3DlGDpdL7J-kerc8bg_swDxFP0xsg-wtkhn6Cbq8vri2_F5sfX7xefN4WqmjYVW0MrqVkFxsi2KaWpiexUS6niW9lpQw3ncstkzVWrZGs6TRilZdN0RnOAmp2gD3veMfiHCWISg40K-l468FMUlLe8403VtS-BMsa6XJCh53uoygLEAEaMwQ4yzIISsagjduJfdcSijiAsxzLSu0OfaTuA_lv6LEcGfNkDIC_mt4UgDjTaBlBJaG9f1ufTfzSqt84q2d_DDHHnp-Dy6gUVsRRE_Fp8stiENmyxCGdPTYO_PQ</recordid><startdate>20160602</startdate><enddate>20160602</enddate><creator>Martins, D.F</creator><creator>Turnes, B.L</creator><creator>Cidral-Filho, F.J</creator><creator>Bobinski, F</creator><creator>Rosas, R.F</creator><creator>Danielski, L.G</creator><creator>Petronilho, F</creator><creator>Santos, A.R.S</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope></search><sort><creationdate>20160602</creationdate><title>Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes</title><author>Martins, D.F ; Turnes, B.L ; Cidral-Filho, F.J ; Bobinski, F ; Rosas, R.F ; Danielski, L.G ; Petronilho, F ; Santos, A.R.S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-bf14ad34effa862af50a9c811c7ba9df1f77ab3a57c8ca8f9d03112669fd7ee53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antioxidants - metabolism</topic><topic>Catalase - metabolism</topic><topic>Disease Models, Animal</topic><topic>Freund's Adjuvant</topic><topic>Hot Temperature</topic><topic>Hyperalgesia - metabolism</topic><topic>Hyperalgesia - therapy</topic><topic>inflammation</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - therapy</topic><topic>Interleukin-10 - metabolism</topic><topic>Interleukin-1beta - metabolism</topic><topic>low-level light therapy</topic><topic>Male</topic><topic>Mice</topic><topic>Neurology</topic><topic>Oxidative Stress - physiology</topic><topic>Pain - metabolism</topic><topic>Pain Management - instrumentation</topic><topic>Pain Management - methods</topic><topic>persistent pain</topic><topic>Phototherapy - instrumentation</topic><topic>Phototherapy - methods</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Thiobarbituric Acid Reactive Substances - metabolism</topic><topic>Touch</topic><topic>Treatment Outcome</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martins, D.F</creatorcontrib><creatorcontrib>Turnes, B.L</creatorcontrib><creatorcontrib>Cidral-Filho, F.J</creatorcontrib><creatorcontrib>Bobinski, F</creatorcontrib><creatorcontrib>Rosas, R.F</creatorcontrib><creatorcontrib>Danielski, L.G</creatorcontrib><creatorcontrib>Petronilho, F</creatorcontrib><creatorcontrib>Santos, A.R.S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martins, D.F</au><au>Turnes, B.L</au><au>Cidral-Filho, F.J</au><au>Bobinski, F</au><au>Rosas, R.F</au><au>Danielski, L.G</au><au>Petronilho, F</au><au>Santos, A.R.S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2016-06-02</date><risdate>2016</risdate><volume>324</volume><spage>485</spage><epage>495</epage><pages>485-495</pages><issn>0306-4522</issn><eissn>1873-7544</eissn><abstract>•LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity. Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesia and inflammatory processes. Nevertheless, scientific data on the mechanisms responsible for the therapeutic effect of LEDT are still insufficient. Thus, this study investigated the analgesic, anti-inflammatory and anti-oxidative effect of LEDT in the model of chronic inflammatory hyperalgesia. Experimental procedures: Mice injected with Complete Freund’s Adjuvant (CFA) underwent behavioral, i.e. mechanical and hot hyperalgesia; determination of cytokine levels (tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-10), oxidative stress markers (protein carbonyls and thiobarbituric acid reactive species (TBARS)) and antioxidant enzymes (catalase (CAT) and superoxide dismutase (SOD)). Additionally, mice were pretreated with either naloxone or fucoidin and mechanical hyperalgesia was assessed. Results: LEDT inhibited mechanical and thermal hyperalgesia induced by CFA injection. LEDT did not reduce paw edema, neither influenced the levels of TNF-α and IL1-β; although it increased the levels of IL-10. LEDT significantly prevented TBARS increase in both acute and chronic phases post-CFA injection; whereas protein carbonyl levels were reduced only in the acute phase. LEDT induced an increase in both SOD and CAT activity, with effects observable in the acute but not in the chronic. And finally, pre-administration of naloxone or fucoidin prevented LEDT analgesic effect. Conclusions: These data contribute to the understanding of the neurobiological mechanisms involved in the therapeutic effect of LEDT as well as provides additional support for its use in the treatment of painful conditions of inflammatory etiology.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>27001179</pmid><doi>10.1016/j.neuroscience.2016.03.035</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-4522
ispartof Neuroscience, 2016-06, Vol.324, p.485-495
issn 0306-4522
1873-7544
language eng
recordid cdi_proquest_miscellaneous_1787976498
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antioxidants - metabolism
Catalase - metabolism
Disease Models, Animal
Freund's Adjuvant
Hot Temperature
Hyperalgesia - metabolism
Hyperalgesia - therapy
inflammation
Inflammation - metabolism
Inflammation - therapy
Interleukin-10 - metabolism
Interleukin-1beta - metabolism
low-level light therapy
Male
Mice
Neurology
Oxidative Stress - physiology
Pain - metabolism
Pain Management - instrumentation
Pain Management - methods
persistent pain
Phototherapy - instrumentation
Phototherapy - methods
Superoxide Dismutase - metabolism
Thiobarbituric Acid Reactive Substances - metabolism
Touch
Treatment Outcome
Tumor Necrosis Factor-alpha - metabolism
title Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T10%3A40%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Light-emitting%20diode%20therapy%20reduces%20persistent%20inflammatory%20pain:%20Role%20of%20interleukin%2010%20and%20antioxidant%20enzymes&rft.jtitle=Neuroscience&rft.au=Martins,%20D.F&rft.date=2016-06-02&rft.volume=324&rft.spage=485&rft.epage=495&rft.pages=485-495&rft.issn=0306-4522&rft.eissn=1873-7544&rft_id=info:doi/10.1016/j.neuroscience.2016.03.035&rft_dat=%3Cproquest_cross%3E1783339787%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1783339787&rft_id=info:pmid/27001179&rft_els_id=S0306452216300057&rfr_iscdi=true